Benign Prostatic Hyperplasia Treatment Devices Market

Benign Prostatic Hyperplasia Treatment Devices Market contains market size and forecasts of Benign Prostatic Hyperplasia (BPH) Treatment Devices in global, including the following market information:

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Benign Prostatic Hyperplasia (BPH) Treatment Devices companies in 2021 (%)

The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices include Advin Urology, Biolitec, Boston Scientific Corporation, CONMED, Convergent Laser Technologies, CoreTherm Medical, Inc. (ProstaLund), HistoSonics, Inc., JenaSurgical GmbH and KARL STORZ, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Benign Prostatic Hyperplasia (BPH) Treatment Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, by Type, 2021 (%)

Surgical Treatment

Minimally Invasive Treatment

Laser Treatment

Other

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, by Application, 2021 (%)

Fertility Clinics

Hospitals

Others

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues share in global market, 2021 (%)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Advin Urology

Biolitec

Boston Scientific Corporation

CONMED

Convergent Laser Technologies

CoreTherm Medical, Inc. (ProstaLund)

HistoSonics, Inc.

JenaSurgical GmbH

KARL STORZ

LISA Laser Products GmbH

Lumenis Ltd.

Medifocus, Inc.

Endo International

Medtronic

Siemens

Olympus

Urologix

NeoTract

Urotech

Baxter International